Question 1

Does Avoro Capital Advisors own ACAD stock?

Accepted Answer

No. Avoro Capital Advisors exited its ACAD (Acadia Pharmaceuticals) position in Q2 2022. Its Q1 2022 13F listed 2,275,000 shares worth $55.1M.

Question 2

How many shares of ACAD does Avoro Capital Advisors own?

Accepted Answer

None since Q2 2022, when Avoro Capital Advisors exited the position. Its Q1 2022 13F listed 2,275,000 shares worth $55.1M.

Question 3

What is Avoro Capital Advisors' ACAD position worth?

Accepted Answer

Avoro Capital Advisors' ACAD position was worth $55.1M in its Q1 2022 13F, before the exit in Q2 2022.

Question 4

Is Avoro Capital Advisors buying or selling ACAD?

Accepted Answer

In Q2 2022, Avoro Capital Advisors exited its entire ACAD position.

Question 5

When did Avoro Capital Advisors first buy ACAD?

Accepted Answer

Avoro Capital Advisors already held ACAD in its Q1 2019 13F, the earliest on record, and listed it in 10 quarterly 13F filings.